Back to News
AI
Beyond ADMET: AI for medicines safety stakeholder survey
Www.gov.uk·September 16, 2026·1 min read
AI Summary
The MHRA and the Regulatory Innovation Office (RIO) invite organisations to share their views on the use of artificial intelligence (AI) in medicines development.
From the source
The MHRA and the Regulatory Innovation Office (RIO) invite organisations to share their views on the use of artificial intelligence (AI) in medicines development.
The full text couldn't be loaded here (the source may require a subscription).
View original at Www.gov.ukKeep reading
Artificial Intelligence Boom: The Biggest Growing Presence on Campus - Cal Timescaltimes.org · 10h agoThe Leftist Split Over AI DoomWired — AI · 10h agoUS and China experts push for shared rules banning AI control over nuclear weaponsThe Decoder · 10h agoSatya Nadella calls for AI innovations to enhance accessibility and control in agriculture - ET CIOcio.economictimes.indiatimes.com · 10h ago
Was this useful?